Asish Ghosh to Protein Kinase Inhibitors
This is a "connection" page, showing publications Asish Ghosh has written about Protein Kinase Inhibitors.
Connection Strength
0.195
-
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors. Clin Cancer Res. 2015 May 01; 21(9):2115-26.
Score: 0.111
-
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. Blood. 2011 Feb 10; 117(6):1928-37.
Score: 0.083